Telomere-targeting agent demonstrates potent anticancer activity in aggressive pediatric brain cancer in preclinical study

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

The UF Health Proton Therapy Institute enhanced its playroom, a respite for its pediatric patients, significantly with innovative technology that promotes therapeutic engagement, with an 86” interactive gaming wall that features educational and sensory software.

March 29, 2024

Vol.50 No.13

Clinical Roundup

USC researchers find genetic variant contributing to disparities in childhood leukemia risk

Researchers from the University of Southern California found a genetic variant contributing to disparities in childhood leukemia risk. The variant, located on the IKZF1 gene, helps explain why Hispanic/Latino children face a higher risk of acute lymphoblastic leukemia and offers insights about what causes the disease.

March 29, 2024

Vol.50 No.13

In Brief

Fox Chase’s Joshua Cohn named consultant to Shriners Children’s Philadelphia

Joshua Cohn, associate professor in the Department of Urology at Fox Chase Cancer Center and a member of the Fox Chase – Temple Urologic Institute, was named a consultant at Shriners Children’s Philadelphia.

February 16, 2024

Vol.50 No.07

In Brief

Alexandra Miller named chief of neuro-oncology and co-director of Brain and Spine Tumor Center at NYU Perlmutter

Alexandra Miller, a neurologist and neuro-oncologist specializing in treating primary brain tumors, has been named as the chief of the Division of Neuro-Oncology and co-director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, effective Jan. 29.

January 26, 2024

Vol.50 No.04

Clinical Roundup

City of Hope Children’s Cancer Center, Children’s Oncology Group conduct clinical trial seeking to prevent heart failure among pediatric cancer survivors

The largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure found that carvedilol, a blood vessel relaxing medication, is safe for childhood cancer survivors and may improve important markers of heart injury sustained as a result of chemotherapy exposure.

January 12, 2024

Vol.50 No.02

In Brief

Glenn Lesser named deputy director of the Atrium Health Wake Forest Baptist CCC

Glenn J. Lesser was named deputy director of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center.

December 01, 2023

Vol.49 No.44

Telomere-targeting agent demonstrates potent anticancer activity in aggressive pediatric brain cancer in preclinical study

YOU MAY BE INTERESTED IN

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

USC researchers find genetic variant contributing to disparities in childhood leukemia risk

Fox Chase’s Joshua Cohn named consultant to Shriners Children’s Philadelphia

Alexandra Miller named chief of neuro-oncology and co-director of Brain and Spine Tumor Center at NYU Perlmutter

City of Hope Children’s Cancer Center, Children’s Oncology Group conduct clinical trial seeking to prevent heart failure among pediatric cancer survivors

Glenn Lesser named deputy director of the Atrium Health Wake Forest Baptist CCC

Renew today!

Subscriber content

Login